Long Term Prevention of Nausea and Vomiting in Gynecologic Laparoscopy

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

To compare postoperative nausea and vomiting (PONV) and perioperative outcomes of gynecologic patients undergoing laparoscopic surgery after scheduled administration of intravenous Ramosetron during hospital stays.

• Randomized controlled arm : Placebo versus Ramosetron injection

• Administration schedule : immediate postoperative status, 12 hrs after surgery, 36hrs after surgery

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Health Insurance Service Ilsan Hospital
• Treatments: Ramosetron

Criteria

Inclusion Criteria:

• Age: 18< or =, = or <70 with benign gynecologic disease

• ASA-Class I-II

• No-definite malignancy by US, CT/MRI, CA 125 < 500IU/ml

• Non-smoker

Exclusion Criteria:

• Conversion to laparotomy

• Hx of malignancy

• Smoker

• Suspicious malignancy